Skip to content

Exploring the Effects of Aquatic Exercise on Cardiovascular Function in Older Adults

Exploring the Effects of Aquatic Exercise on Cardiovascular Function in Older Adults

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04308057
Acronym
ACELA
Enrollment
100
Registered
2020-03-13
Start date
2019-12-01
Completion date
2022-08-30
Last updated
2022-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases

Brief summary

Cardiovascular ageing is implicated in the development of cardiovascular disease (CVD). Aquatic exercise is being considered as a co-adjuvant form of rehabilitation, but there is limited evidence for its cardiovascular risk-reduction properties for older people. Our study aims to address this by exploring the cardiovascular effects of long-term aquatic exercise in older adults in comparison to those who are either inactive or engaged in land-based/mixed training by measurement of micro- and macro-circulation.

Interventions

Participants belonging to Group D (sedentary group) will be randomised 1-to-1 between remaining sedentary (n=20) and following a self-managed, 8-week, aquatic-based exercise programme (n=20). The latter group will be offered an 8-week access to pool facilities. For Group D participants, all baseline assessments will be repeated at 8 weeks.

Sponsors

Sheffield Hallam University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
55 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* being over 55 years of age and normotensive (e.g., \<140/90 mm Hg).

Exclusion criteria

* any overt chronic disease which would affect microvascular functioning, * anaemia (irrespective of whether an iron supplementation course is followed or not) * a recent (3 months' ago) major surgery * None of the participants were undertaking high intensity interval training of any form.

Design outcomes

Primary

MeasureTime frameDescription
Nitric oxide-mediated, macro (arterial)- circulatory function.Baseline.We will use FMD as a measure of endothelium-dependent, nitric oxide (NO)-mediated, macro (arterial)- circulatory function. Baseline scanning to assess resting vessel diameter will be recorded over 3 minutes, following a 10-minute resting period. A rapid inflation-deflation pneumatic cuff placed immediately distal to the elbow joint will be used to as an FMD stimulus.

Secondary

MeasureTime frameDescription
Anthropometry - 2Baseline.Body mass will be measured.
Microcirculatory functionBaseline.Skin blood flow will be measured as cutaneous red blood cell flux using a Laser Doppler Flowmeter (LDF). Local thermal hyperaemia will be induced using a heating disc surrounding the probe. The probe will be attached to the skin using a double-sided adhesion sticker. Participants will be rested in a supine position in a temperature-controlled room with a constant ambient temperature of 24° C for 35 minutes. Heart rate and diastolic and systolic blood pressure was recorded from the left arm at 5-minute intervals throughout the protocol (Dinamap Dash 2500, GE Healthcare, USA). Baseline skin blood flow data will be recorded for 5 minutes with the local heating disc temperature set at 30° C. Following this, rapid local heating will be initiated to obtain maximal vasodilation and the temperature will be increased by 1° C every 10 seconds until 42° C was reached. This will then be maintained for 30 minutes following, which the test will be completed.
Anthropometry - 1Baseline.Stature, waist and hip circumferences will be measured (all in cms).
SF-IPAQBaseline.The SF-IPAQ questionnaire will be completed, to assess physical activity levels.
EQ-5D-5LBaseline.The EQ5D-5L questionnaire will be completed, to support assessment of quality of life.
Feasibility outcome - 1BaselineRecruitment rate (% of those expressing an interest, being actually recruited).
Feasibility outcome - 28 weeksAdherence rate (% of those recruited completing at least 75% of the prescribed number of exercise sessions).
Feasibility outcome - 38 weeksRetention rate (% of those recruited completing the post-intervention assessments).
Q-RiskBaseline.The online Q-Risk questionnaire will be competed, which assesses the risk of cardiovascular disease risk

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026